0001847837-21-000001.txt : 20210303
0001847837-21-000001.hdr.sgml : 20210303
20210303152635
ACCESSION NUMBER: 0001847837-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210303
DATE AS OF CHANGE: 20210303
EFFECTIVENESS DATE: 20210303
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Asylia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001847837
IRS NUMBER: 842626885
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-391131
FILM NUMBER: 21708685
BUSINESS ADDRESS:
STREET 1: 3139 W HOLCOMBE BLVD
STREET 2: SUITE 445
CITY: HOUSTON
STATE: TX
ZIP: 77025
BUSINESS PHONE: 617-921-9645
MAIL ADDRESS:
STREET 1: 3139 W HOLCOMBE BLVD
STREET 2: SUITE 445
CITY: HOUSTON
STATE: TX
ZIP: 77025
D
1
primary_doc.xml
X0708
D
LIVE
0001847837
Asylia Therapeutics, Inc.
3139 W HOLCOMBE BLVD
SUITE 445
HOUSTON
TX
TEXAS
77025
617-921-9645
DELAWARE
None
None
Corporation
true
2019
Elan
Ezickson
3139 W Holcombe Boulevard
Suite 445
Houston
TX
TEXAS
77025
Executive Officer
Director
Joseph
Kekst
3139 W Holcombe Boulevard
Suite 445
Houston
TX
TEXAS
77025
Director
Jeno
Gyuris
3139 W Holcombe Boulevard
Suite 445
Houston
TX
TEXAS
77025
Executive Officer
Director
Biotechnology
Decline to Disclose
- 06b
false
2021-02-16
false
true
false
0
16193628
8193628
8000000
false
1
0
0
0
false
Asylia Therapeutics, Inc.
/s/ Elan Ezickson
Elan Ezickson
President
2021-03-03